UTI Mutual Fund
← All mutual funds

UTI - Healthcare Fund - Direct Plan - Growth

UTI Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 10/09/2026

390.86

1D

-0.45%

1Y

+17.28%

Key stats

Expense ratio
1.28%
AUM
₹1.44 K Cr
Launched
01/01/2013
Fund manager
Kamal Gada
Portfolio turnover
0.28%
Risk
Very High Risk
Min lump-sum
₹5,000
Min SIP
₹500/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

UTI - Healthcare Fund - Direct Plan - Growth

12/08/2026 to 10/09/2026

O - H - L -

393.22386.5512/08/202610/09/2026
1W-0.37%
1M+0.01%
3M+10.62%
6M+22.15%
1Y+17.28%
3Y+24.32%
5Y+16.31%
MAX+719.07%

Top holdings

46 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    8.71%
  • 2.

    Divi's Laboratories Ltd

    Healthcare

    5.57%
  • 3.

    Ajanta Pharma Ltd

    Healthcare

    4.80%
  • 4.

    Caplin Point Laboratories Ltd

    Healthcare

    3.95%
  • 5.

    Lupin Ltd

    Healthcare

    3.59%
  • 6.

    Gland Pharma Ltd

    Healthcare

    3.56%
  • 7.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    3.46%
  • 8.

    Dr Reddy's Laboratories Ltd

    Healthcare

    3.10%
  • 9.

    Alkem Laboratories Ltd

    Healthcare

    3.10%
  • 10.

    Net Current Assets

    2.90%
  • 11.

    Global Health Ltd

    Healthcare

    2.81%
  • 12.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    2.76%
  • 13.

    Ipca Laboratories Ltd

    Healthcare

    2.68%
  • 14.

    Fortis Healthcare Ltd

    Healthcare

    2.58%
  • 15.

    Anthem Biosciences Ltd

    Healthcare

    2.50%
  • 16.

    Procter & Gamble Health Ltd

    Healthcare

    2.41%
  • 17.

    Rainbow Childrens Medicare Ltd

    Healthcare

    2.34%
  • 18.

    Sai Life Sciences Ltd

    Healthcare

    2.20%
  • 19.

    Jupiter Life Line Hospitals Ltd

    Healthcare

    2.18%
  • 20.

    Cohance Lifesciences Ltd

    Healthcare

    2.17%
  • 21.

    Marksans Pharma Ltd

    Healthcare

    2.17%
  • 22.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    2.11%
  • 23.

    Viyash Scientific Ltd

    Healthcare

    1.98%
  • 24.

    Aster DM Quality Care Ltd Ordinary Shares

    Healthcare

    1.94%
  • 25.

    Aurobindo Pharma Ltd

    Healthcare

    1.84%
  • 26.

    Sudeep Pharma Ltd

    Healthcare

    1.71%
  • 27.

    Dr. Lal PathLabs Ltd

    Healthcare

    1.67%
  • 28.

    Metropolis Healthcare Ltd

    Healthcare

    1.64%
  • 29.

    Cipla Ltd

    Healthcare

    1.61%
  • 30.

    Biocon Ltd

    Healthcare

    1.55%
  • 31.

    Eris Lifesciences Ltd Registered Shs

    Healthcare

    1.33%
  • 32.

    Vijaya Diagnostic Centre Ltd

    Healthcare

    1.30%
  • 33.

    Pfizer Ltd

    Healthcare

    1.21%
  • 34.

    Windlas Biotech Ltd

    Healthcare

    1.17%
  • 35.

    Alembic Pharmaceuticals Ltd

    Healthcare

    1.16%
  • 36.

    Blue Jet Healthcare Ltd

    Healthcare

    1.13%
  • 37.

    Laxmi Dental Ltd

    Healthcare

    1.02%
  • 38.

    Emcure Pharmaceuticals Ltd

    Healthcare

    0.99%
  • 39.

    Manipal Health Enterprises Limited

    0.91%
  • 40.

    Sanofi Consumer Healthcare India Ltd

    Healthcare

    0.81%
  • 41.

    Krishna Institute of Medical Sciences Ltd

    Healthcare

    0.81%
  • 42.

    Aarti Pharmalabs Ltd

    Healthcare

    0.73%
  • 43.

    Orchid Pharma Ltd

    Healthcare

    0.73%
  • 44.

    Jubilant Pharmova Ltd

    Healthcare

    0.61%
  • 45.

    Syngene International Ltd

    Healthcare

    0.46%
  • 46.

    Clearing Corporation Of India Ltd. Std - Margin

    0.02%

Sector allocation

  • Healthcare96.17%
  • Unclassified3.83%

Comparable peers

  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+22.13%
    3Y+24.61%
    -

  • Mirae Asset Healthcare Growth Direct Plan

    Mirae Healthcare (G) · ₹3.44 K Cr AUM

    1Y+20.35%
    3Y+23.20%
    -

  • LIC Healthcare Growth Direct Plan

    LIC Healthcare (G) · ₹97.60 Cr AUM

    1Y+17.81%
    3Y+23.11%
    -

  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+17.28%
    3Y+24.42%
    -

  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM

    1Y+9.79%
    3Y+25.46%
    -

Investment objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Scheme details

Scheme code
120782
Fund house
UTI Mutual Fund
Category
Open Ended
Type
Equity Scheme
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF789F01TO9
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page